 |
This Congress has been declared free of tobacco smoke |
 |
Buenos Aires, Capital of Book 2011 |
 |
 |
| Official Domestic Carrier | Official International Carrier |
 |
MCI Buenos Aires Avenida Santa Fe 1970, 1º Piso, Oficina 1 C1123AAO, Buenos Aires, Argentina Phone: +54 11 5252 9801 / Fax: +54 11 4813 0073 e-mail - Web |
EspañolMonday, September 19
| 9.00-10.30 | Core Symposium CS1 |
FUNCTIONAL PSYCHOPATHOLOGY
Chairperson: S. Kapur (UK)
CS1.1 Linking dopamine to salience to psychosis: a feasible project or just a delusion?
S. Kapur (UK)
CS1.2 Brain catecholamines and reward processing in major depression
G. Hasler (Switzerland)
CS1.3 Recruiting endophenotypes in the service of anxiety diagnosis, and their potential clinical implications: the case of OCD
J. Zohar (Israel)
| 9.00-10.30 | Core Symposium CS2 |
RESILIENCE AND RECOVERY IN PERSONS WITH MENTAL DISORDERS
Chairperson: A. Bellack (USA)
CS2.1 Resilience and resources of psychiatric patients: concepts for utilizing them in care
S. Priebe (UK)
CS2.2 Scientific and consumer perspectives on recovery
A. Bellack (USA)
CS2.3 Personal recovery: a journey of change
M. Slade (UK)
| 9.00-10.30 | Core Symposium CS3 |
CHILDREN WITH MENTAL DISORDERS DO BECOME ADULTS
Chairperson: B. Birmaher (USA)
CS3.1 The changing face of autism: a developmental perspective
F. Volkmar (USA)
CS3.2 Adolescent and adult outcome in attention deficit/hyperactivity disorder and its predictors
L. Hechtman (Canada)
CS3.3 Mood disorders across the lifespan
B. Birmaher (USA)
| 9.00-10.30 | Special Symposium SPS1 |
DEVELOPING THE ICD-11 CLASSIFICATION OF MENTAL DISORDERS: FIELD STUDIES AND GLOBAL PERSPECTIVES
Chairpersons: M. Maj (Italy), G. Reed (Switzerland)
SPS1.1 An international and multilingual survey of psychiatrists’ experiences with ICD-10 and priorities for ICD-11
G.M. Reed, M. Maj, P. Esparza, J. Correia (Switzerland/Italy)
SPS1.2 Using paired comparisons and multidimensional scaling to map clinicians’ conceptualizations of mental disorders
M.E. Medina-Mora, M.C. Roberts, G.M. Reed, D.K. Johnson (Mexico/USA/Switzerland)
SPS1.3 Clinicians’ working taxonomies of mental disorders: implications for ICD-11
J.L. Ayuso-Mateos, G.M. Reed, K. Hooppell, C. Matsumoto (Spain/Switzerland/Japan)
SPS1.4 Contributions of Latin American scientific literature to the development of ICD-11
D. Razzouk, B. Nogueira, J.J. Mari (Brazil)
SPS1.5 Use and importance of ICD-10 mental disorders diagnoses in Japan: a survey of experts
T. Maruta, C. Matsumoto, M. Iimori (Japan)
| 9.00-10.30 | Special Forum SF1 |
RELATIONSHIPS OF PHYSICIANS, MEDICAL ORGANIZATIONS AND PROFESSIONAL ASSOCIATIONS WITH THE PHARMACEUTICAL INDUSTRY
S. Tyano (Israel), P. Appelbaum (USA), A. Javed (UK), J. Arboleda-Florez (Canada), C. Soldatos (Greece)
| 9.00-10.30 | Regular Symposium RS1 |
COGNITIVE REMEDIATION THERAPY IN SCHIZOPHRENIA: STATE OF THE ART
Chairpersons: V. Roder (Switzerland), A. Medalia (USA)
RS1.1 Integrated approaches to treating neurocognition and social cognition
A. Medalia (USA)
RS1.2 Efficacy of integrated cognitive remediation therapy approaches in schizophrenia
V. Roder, S.J. Schmidt, D.R. Mueller (Switzerland)
RS1.3 Social cognitive remediation therapy
D.L. Roberts (USA)
RS1.4 Neurocognitive remediation approaches in the treatment of schizophrenic patients
I. Fuentes, J.C. Ruiz, C. Dasí, M. Soler (Spain)
| 9.00-10.30 | Regular Symposium RS2 |
THE ECONOMIC COLLAPSE OF ICELAND IN 2008: MENTAL HEALTH CONSEQUENCES IN A REGIONAL CONTEXT
Chairperson: P. Matthiasson (Iceland)
RS2.1 Emergency visits and use of primary care and psychiatric services during the financial crisis in Iceland
H. Olafsdottir (Iceland)
RS2.2 Impact of economic collapse on bed usage in psychiatry in Iceland
E. Sigurdsson (Iceland)
RS2.3 The pattern of drug use and drug-related admissions to psychiatric wards after the financial crisis in Iceland
A. Magnusson (Iceland)
RS2.4 The economic collapse of Iceland in 2008: mental health consequences in a regional context
P. Matthiasson (Iceland)
| 9.00-10.30 | Regular Symposium RS3 |
IMAGES OF PSYCHIATRY: IMPROVING THE PERCEPTION OF PSYCHIATRY AMONG THE GENERAL PUBLIC AND OTHER MEDICAL PROFESSIONALS
Chairperson: S. Hollins (UK)
RS3.1 Recruitment into psychiatry: challenges and solutions
K.A. Seed, G. Lydall, A. Malik, R. Howard, D. Bhugra (UK)
RS3.2 Stigmatization of psychiatry and psychiatrists: results of an international control-group study
W. Gaebel, K. Samjeske, J. Zielasek (Germany)
RS3.3 Images of psychiatry – a Royal College of Psychiatrists campaign 2005-2008
S. Hollins (UK)
| 9.00-10.30 | Section Symposium SS1 |
HALLUCINATORY VOICES: INTEGRATING CLINICAL, RESEARCH AND THERAPEUTIC PERSPECTIVES (organized by the WPA Sections on Clinical Psychopathology and on Psychotherapy)
Chairpersons: A. Raballo (Denmark/Italy), A. Preti (Italy)
SS1.1 Hallucinatory voices: history and epistemology
G.E. Berrios (UK)
SS1.2 Auditory-verbal hallucinations: a clinical-phenomenological approach
P. Handest, F. Larøi, A. Raballo (Denmark/Belgium/Italy)
SS1.3 Contrasting monosymptomatic patients with hallucinations vs.delusions: empirical findings on course and outcome
J. Evensen, J.A. Røssberg, U. Haahr, W.T. Hegelstad, I. Inge Joa, J.O. Johannessen, H. Langeveld, T.K. Larsen, I. Melle, S. Opjordsmoen, B. Rund, K. Simonsen, K. Sundet, P. Vaglum, S. Friis, T. McGlashan (Norway/Denmark/USA)
SS1.4 A voice a-while ago: psychosocial treatment of hallucinations
A. Preti, M. Cella (Italy/UK)
| 9.00-10.30 | Section Symposium SS2 |
NORMALITY AND PSYCHOPATHOLOGY: MEASUREMENT ASPECTS AND TOOLS (organized by the WPA Section on Measurement Instruments in Psychiatric Care)
Chairpersons: V. Starcevic (Australia), A. Janca (Australia)
SS2.1 Towards a definition of mental disorder: conceptual issues
D. Kecmanovic (Australia)
SS2.2 Normality and psychopathology: where do the addictions fit?
L.B. Cottler (USA)
SS2.3 Normality and anxiety disorders: drawing the line to improve utility and conceptual validity of the anxiety disorders
V. Starcevic (Australia)
SS2.4 Measuring mental health and psychopathology in Aboriginal culture
A. Janca (Australia)
SS2.5 Medical students’ mental health: resilience and psychopathology
M. Latas (Serbia)
| 9.00-10.30 | Section Symposium SS3 |
COGNITIVE STYLES IN EATING DISORDERS: NEUROENDOCRINE AND NEUROPSYCHOLOGICAL ASPECTS (organized by the WPA Section on Eating Disorders)
Chairpersons: P. Monteleone (Italy), F. Brambilla (Italy)
SS3.1 Investigation of steroid hormones and cognitive functioning in eating disorders
P. Monteleone, S. Galderisi, P. Bucci, C. Di Filippo, M. Maj (Italy)
SS3.2 Repetitive transcranial magnetic stimulation reduces food craving and salivary cortisol levels in bulimic disorders
A. Claudino, F. Van den Eynde, A. Mogg, D. Stahl, M. Andiappan, W. Ribeiro, T. Dew, L. Horrell, J. Kalthoff, R. Uher, I. Campbell, U. Schmidt (UK/Brazil)
SS3.3 Oxytocin: a novel treatment in anorexia nervosa?
J. Russell, A. Guastella, K. Tchanturia, U. Schmidt, J. Treasure, D. Carson, S. Maguire, R. Uptala-Kumar, S. Abraham (Australia/UK)
SS3.4 Central coherence in eating disorders: a systematic review
C. López, K. Tchanturia, D. Stahl, J. Treasure (Chile/UK)
SS3.5 A group program for bulimic patients: recognition of cognitive problems involved in the relationships
G. Onofrio (Argentina)
| 9.00-10.30 | Zonal Symposium ZS1 |
MATERNAL AND CHILD HEALTH: THE EMOTIONAL PERSPECTIVES
(organized by the WPA Central and Western Africa Zone)
Chairpersons: J.D. Adeyemi (Nigeria), O. Gureje (Nigeria)
ZS1.1 Emotional distress among infertile couples in South East Nigeria
G.M. Onyeama (Nigeria)
ZS1.2 Eating pattern and psychiatric morbidity: a study of primigravid women
I.C. Egegbara, J.D. Adeyemi (Nigeria)
ZS1.3 Improving maternal and child health in Nigeria through perinatal mental health interventions
O. Omigbodun, K. Adediran, A. Orimadegun, T. Bella, D. Morhasen-Bello, Y. Adeniyi, V. Makanjuola, Y. Ogunbode, A. Omigbodun (Nigeria)
ZS1.4 Child and adolescent mental health services: an unmet need in West Africa
A. Osei (Ghana)
| 9.00-10.30 | Zonal Symposium ZS2 |
BUILDING EXPERTISE AND LEADERSHIP IN MOOD DISORDERS IN PACIFIC ISLAND COUNTRIES (organized by the WPA Australasia and South Pacific Zone)
Chairpersons: V. Manicavasagar (Australia), J. Freidin (Australia)
ZS2.1 Improving the identification and management of mood disorders indeveloping countries of the Asia-Pacific region
V. Manicavasagar, I. Blignault, G. Parker (Australia)
ZS2.2 Meeting the mental health challenge in Fiji
A. Andrews, O. Chang (Fiji)
ZS2.3 Developing mental health services in the Solomon Islands: achievements
and challenges
P. Orotaloa, A. Araitewa, J. Dusaru, J. Kaota, W. Same, I. Blignault (Solomon Islands)
ZS2.4 Establishing mental health policy and services in Vanuatu
J. Iaurel, S. Natuman, M. Paul, R. Nampon, I. Blignault (Vanuatu)
| 9.00-10.30 | Simposio Regular RSp/e1 |
VOCES EN EL CEREBRO: UN MISTERIO POR RESOLVER
Presidente: C. Leal (España)
RSp/e1.1 Alucinaciones: categorías o dimensiones
J.C. Gonzalez, M. Renovell (España)
RSp/e1.2 Alucinaciones: una compleja interacción gene-ambiente
J. Sanjuan, R. Sales (España)
RSp/e1.3 Nuevos tratamientos de las alucinaciones auditivas
E.J. Aguilar, I. Leal (España)
| 9.00-10.30 | Simposio Regular RSp/e2 |
DEPRESSÃO PÓS-PARTO: FATORES DE RISCO PSICOSSOCIAIS, DESENVOLVIMENTO DE INSTRUMENTO DIAGNÓSTICO E GENÉTICA
Presidente: H. Correa (Brasil)
RSp/e2.1 Associaçao entre o gene do BDNF, variáveis clínicas e sócio-demograficas e a depressao pos-parto
H. Correa (Brasil)
RSp/e2.2 Escala de depressão pós-parto de Edimburg: análise fatorial e desenvolvimento de uma versão reduzida
L. Malloy-Diniz (Brasil)
RSp/e2.3 Aspectos psicosociais como fatores de risco para a depressao pos-parto
P. Figueira (Brasil)
| 9.00-10.30 | Workshop WOp/e1 |
RESOLUCIÓN DE PROBLEMAS LEGALES EN LA PRÁCTICA PROFESIONAL COTIDIANA
A.A. Mega, E.M. Espector, F.R. Ramírez, M.I. Díaz (Argentina)
| 9.00-10.30 | Workshop WOp/e2 |
CONTROVERSIAS EN NEUROPSIQUIATRÍA: DEMENCIA FRONTOTEMPORAL VS. PSICOSIS DE COMIENZO TARDÍO
R.F. Allegri, R.L. Arizaga, J. Kremer, C.A. Mangone, E.G. Reich, J.A. Ollari, J.A. Ure (Argentina)
| 10.45-12.15 | KEYNOTE LECTURES |
Chairperson: M. Maj (Italy)
KL1 Classifications and diagnostic systems in psychiatry: our heritage and our future
N. Sartorius (Switzerland)
KL2 Past, present, future of the genetics of mental disorders
P. McGuffin (UK)
| 10.45-12.15 | Regular Symposium RS4 |
MERGING EVIDENCE AND CLINICAL PRACTICE IN THE MANAGEMENT OF DEPRESSION: THE CANMAT EXPERIENCE
Chairperson: M.-J. Filteau (Canada)
RS4.1 Psychotherapy alone or in combination with antidepressants for major depression
S. Parikh (Canada)
RS4.2 CANMAT clinical guidelines for the management of major depressive disorder: advances in pharmacotherapy for depression
R. Lam (Canada)
RS4.3 Neurostimulation therapies for the management of major depressive disorders in adults: evidence and recommendations
R. Milev (Canada)
RS4.4 Complementary and alternative treatments for major depression: a review
A. Ravindran (Canada)
| 10.45-12.15 | Regular Symposium RS5 |
CURRENT KNOWLEDGE ON THE BEHAVIORAL TRIGGERS AND UNDERLYING BIOLOGY OF SUICIDE
Chairperson: S. Koslow (USA)
RS5.1 Personalized medicine and the risk of suicide: problems and promises
C. Nemeroff (USA)
RS5.2 Cortisol response to a pharmacologic challenge: a marker of future suicide attempt risk
J.G. Keilp, M.A. Oquendo, B.H. Stanley, A.K. Burke, T.B. Cooper, K.M. Malone, J.J. Mann (USA)
RS5.3 Suicide behavior, its endophenotypes and the HPA axis
D. Wasserman, Y. Ben-Efraim, J. Wasserman, M. Sokolowski (Sweden)
RS5.4 Differential hippocampal promoter methylation associates with suicide
B. Labonté, M. Suderman, N. Mechawar, M. Szyf, M. Meaney, G. Turecki (Canada)
| 10.45-12.15 | Regular Symposium RS6 |
GENIUS, ARTS AND PSYCHIATRY
Chairpersons: J.J. López-Ibor Jr. (Spain), O. Doerr (Chile)
RS6.1 Creativity, depression and psychotherapy: the case of the statesman, scientist and poet J.W. Goethe
R. Holm-Hadulla (Germany)
RS6.2 Robert Schumann: the price of creativity
A. Heerlein (Chile)
RS6.3 Melancholy and creativity: the case of Rainer Maria Rilke
O. Doerr (Chile)
RS6.4 Who owns the works of art created by mentally ill people
J.J. López-Ibor Jr. (Spain)
| 10.45-12.15 | Regular Symposium RS7 |
FROM PAPER TO ACTION: INTERNATIONAL INSIGHTS INTO THE MENTAL HEALTH POLICY IMPLEMENTATION GAP
Chairpersons: M. Amering (Austria), R. Warner (USA)
RS7.1 The effect of introducing a capitated payment mechanism forpsychiatric services in Colorado: unanticipated consequences
R. Warner (USA)
RS7.2 From vision to reality
J. Wallcraft (UK)
RS7.3 Improving the relationship of service providers, carers and users inmental health services
S. Rataemane (South Africa)
RS7.4 Some simple rules for lobbying government
J. Freidin (Australia)
RS7.5 Neglected social determinants in psychiatry
M. Amering (Austria)
| 10.45-12.15 | Regular Symposium RS8 |
THE IMPACT OF ENVIRONMENTAL ADVERSITY IN CHILDHOOD
Chairperson: Y. Yazgan (Turkey)
RS8.1 Children exposed to war and other disasters
J. Fayyad (Lebanon)
RS8.2 Bullying: characteristics, identification and interventions
Y.S. Kim (USA)
RS8.3 Gene-environment interactions in the face of childhood adversity
M. State (USA)
| 10.45-12.15 | Regular Symposium RS9 |
IS HIKIKOMORI A JAPANESE CULTURE-BOUND SYNDROME OF SOCIAL WITHDRAWAL OR A GLOBALLY PREVALENT NEW DIAGNOSIS/SYMPTOM ASSOCIATED WITH SOCIOCULTURAL CHANGES?
Chairpersons: N. Shinfuku (Japan), T.A. Kato (Japan)
RS9.1 Hikikomori as a clinical concept in psychiatry
M. Tateno (Japan)
RS9.2 Diagnosis of Hikikomori: the challenges and prospects of a disorder of social isolation
A.R. Teo (USA)
RS9.3 Home visit program for detecting, evaluating and treating socially withdrawn youth in Korea
Y.S. Lee, T.Y. Choi (South Korea)
RS9.4 Prevalence, diagnosis and treatment of Hikikomori: psychiatrists’ impressions across cultures
T.A. Kato (Japan)
| 10.45-12.15 | Workshop WO1 |
DOES EVIDENCE-BASED MEDICINE APPLY TO PSYCHIATRY SIMPLICITER?
G.E. Berrios, M. Gupta, D. Matusevich, S. Wikinski (UK/Canada/Argentina)
| 10.45-12.15 | Section Symposium SS4 |
PSYCHIATRY, RELIGION AND SPIRITUALITY: CLINICAL ASPECTS
(organized by the WPA Section on Religion, Spirituality and Psychiatry)
Chairperson: P.J. Verhagen (The Netherlands)
SS4.1 Science (psychiatry) and religion
P.J. Verhagen (The Netherlands)
SS4.2 Obsessive compulsive disorder and religion: a reconnaissance
H. van Megen, P.J. Verhagen (The Netherlands)
SS4.3 Religiousness and alcohol use in the Brazilian population
M.G.S. Nagib, A. Moreira-Almeida, I. Pinsky, M. Sanches, R. Caetano, R. Laranjeira (Brazil/Canada/USA)
SS4.4 Content of religious delusions in schizophrenia
P. Rudaleviciene, T. Stompe, A. Narbekovas (Lithuania/Austria)
SS4.5 Judeo-Christian religious experience and psychiatry: the legacy of William James
S. Dein (UK)
SS4.6 Psychiatry and religion dialogue: a spotlight on anthropologic frameworks and ethical consequences
U. Heckert (Brazil)
SS4.7 An insanity factory: psychiatry and spiritism in Brazil (1900-1950)
A.A.S. Almeida (Brazil)
| 10.45-12.15 | Section Symposium SS5 |
INTERNATIONAL PERSPECTIVES ON QUALITY IMPROVEMENT
(organized by the WPA Section on Quality Assurance in Psychiatry)
Chairpersons: J. McIntyre (USA), W. Gaebel (Germany)
SS5.1 New directions in the development of practice guidelines
J. McIntyre (USA)
SS5.2 Quality of outcome of different trajectories of mental health care
W. Gaebel, S. Kowitz, J. Zielasek (Germany)
SS5.3 Continuous quality improvement and the psychiatrist
J. Halverson (USA)
SS5.4 Is quality of care equal throughout the world?
J. Srinivasaraghavan (USA)
SS5.5 The use of quality improvement learning collaboratives for transformational change in mental health service organizations
N. Adams (USA)
| 10.45-12.15 | Zonal Symposium ZS3 |
ISSUES RELATED TO LEGISLATION REFORMS IN EASTERN EUROPEAN COUNTRIES (organized by the WPA Eastern Europe Zone)
Chairperson: A. Soghoyan (Armenia)
ZS3.1 The role of psychiatric community in reforming guardianship legislation in Central and Eastern European countries
Y. Savenko, D. Bartenev (Russia)
ZS3.2 Activity of non-governmental organizations in the mental health care system in the Kyrgyz Republic
T. Kadyrova, S. Musabaeva (Kyrgyz Republic)
ZS3.3 Belarusian Psychiatric Association: the main directions of activity
S. Igumnov (Belarus)
ZS3.4 Mental health system reform plans in Georgia: opportunities and obstacles
M. Sharashidze (Georgia)
ZS3.5 Legal aspects of mental health system regulation: gaps and priorities in Armenia
A. Soghoyan, M. Khurshudyan (Armenia)
| 10.45-12.15 | Zonal Symposium ZS4 |
MENTAL HEALTH IN CENTRAL AMERICA (organized by the WPA Mexico, Central America and the Caribbean Zone)
Chairperson: M. Sanchez (Nicaragua)
ZS4.1 Report on the assessment of mental health systems in Central American countries using the WHO-AIMS
M. Sanchez (Nicaragua)
ZS4.2 Suicide in Nicaragua
L. Molina (Nicaragua)
ZS4.3 Toward evidence-based mental health planning in Costa Rica
J. Contreras Rojas (Costa Rica)
ZS4.4 Brief psychotherapy interventions in Guatemala
S.-K. Quinto (Guatemala)
| 10.45-12.15 | Simposio Regular RSp/e3 |
DESÓRDENES DEPRESIVOS EN EL NIVEL PRIMARIO DE ATENCIÓN
Presidente: J. Arboleda-Flórez (Canadá)
RSp/e3.1 Psiquiatría en atención primaria de la salud
J. Arboleda-Flórez (Canadá)
RSp/e3.2 Necesidades de mejorar los conocimientos sobre la depresión entre médicos de atención primaria de la salud
M. Suárez Richards (Argentina)
RSp/e3.3 Carga de la depresión para los médicos generalistas en el nivel primario de la atención en Argentina
S. Pujol (Argentina)
RSp/e3.4 El médico general y la psiquiatría; la psiquiatría y el médico general
W. Cueva (Ecuador)
RSp/e3.5 Servicio de hospitalización psiquiátrica de corta estadía (CABL)
M. Fleiderman, E. Sepúlveda (Chile)
| 10.45-12.15 | Simposio Regular RSp/e4 |
PSICOANALISIS Y NEUROCIENCIA: UN ENFOQUE TRANSDISCIPLINARIO EN EL FUTURO DE LA PSIQUIATRIA
Presidente: M. Moncaut (Argentina)
RSp/e4.1 Comprensión del psiquismo y funcionamiento cerebral: su importancia clínica y terapéutica
S.A. Alvano (Argentina)
RSp/e4.2 La eficacia simbólica del fármaco más allá de su acción biológica
L. Montecchi (Italia)
RSp/e4.3 El “fármaco” en la relación terapéutica
M. De Berardinis (Italia)
| 10.45-12.15 | Simposio Regular RSp/e5 |
DO DIAGNÓSTICO E SEUS PROBLEMAS ÉTICOS EM PSIQUIATRIA
Presidente: E. Fortes Silveira Cavalcanti (Brasil)
RSp/e5.1 Crítica do diagnóstico espectral nas esquizofrenias
J.R. Bueno (Brasil)
RSp/e5.2 Bipolaridade e suicídio
H. Correa (Brasil)
RSp/e5.3 Problemas éticos e conflitos de interesse no diagnóstico psiquiátrico
A.G. da Silva (Brasil)
| 10.45-12.15 | Simposio Regular RSp/e6 |
¿ES LA FIBROMIALGIA SOLO UNA DEPRESION ENMASCARADA? DIFERENCIAS CLINICAS, BIOLOGICAS, PRONOSTICAS Y TERAPEUTICAS
Presidente: A. Marquez Lopez Mato (Argentina)
RSp/e6.1 Clínica de las diferencias entre la fibromialgia y depresión
J. Téllez-Vargas (Colombia)
RSp/e6.2 Psiconeuroimmunoendocrinologia de las diferencias entre fibromialgia y depresión
A. Lopez Mato (Argentina)
RSp/e6.3 Pronóstico diferencial entre la fibromialgia y depresión
T. Maresca (Argentina)
RSp/e6.4 Terapéuticas diferencias entre la fibromialgia y depresión
P. Beretta (Argentina)
| 12.30-13.30 | Meet the Expert Session MTE1 |
LONG-TERM TREATMENT OF SCHIZOPHRENIA: WHERE ARE WE, WHAT CAN WE
ACHIEVE? (Organized by Janssen-Cilag)
MTE1.1 The impact of the early intervention in schizophrenia on patient
outcomes
H.-J. Möller (Germany)
MTE1.2 Current evidence for long-acting injectable antipsychotics in the
long-term management of schizophrenia
A. Schreiner (Germany)
| 12.30-14.30 | Oral Communication Session OC1 |
SUBSTANCE ABUSE
| 12.30-14.30 | Oral Communication Session OC2 |
FIRST-EPISODE PSYCHOSIS
| 12.30-14.30 | Oral Communication Session OC3 |
IMPULSE CONTROL DISORDERS AND FORENSIC PSYCHIATRY
| 12.30-14.30 | Oral Communication Session OC4 |
PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY (I)
| 12.30-14.30 | Oral Communication Session OC5 |
HOSPITAL AND COMMUNITY CARE (I)
| 12.30-14.30 | Oral Communication Session OC6 |
ETHICAL AND EPISTEMOLOGICAL ISSUES
| 12.30-14.30 | Poster Session PO2 |
PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY
| 12.30-14.30 | Sponsored Symposium SPE2 |
CHALLENGING DEPRESSIVE SYMPTOMS IN MOOD DISORDERS (Organized by
AstraZeneca)
Chairperson: S. Kasper (Austria)
SPE2.1 Treatment options in bipolar disorder: a question of balance
M. Tohen (USA)
SPE2.2 Insights into the potential mechanisms of efficacy of atypical
antipsychotics
L. Yatham (Canada)
SPE2.3 Complexities in practice
G. Vázquez (Argentina)
| 12.30-14.30 | Sponsored Symposium SPE3 |
FACING THE COMPLEX CHALLENGES OF ACHIEVING MEANINGFUL REMISSION WITH ANTIPSYCHOTIC TREATMENTS (Organized by Lundbeck)
Chairperson: E. Vieta (Spain)
SPE3.1 Managing the complex forms of bipolar I disorder and schizophrenia:
beyond symptomatic remission
E. Vieta (Spain)
SPE3.2 Receptor pharmacology of asenapine, an atypical antipsychotic:
differentiation and clinical relevance
M. Shahid (UK)
SPE3.3 Achieving effective remission with asenapine for patients with bipolar I
disorder
R. McIntyre (Canada)
SPE3.4 Improving patient outcomes in schizophrenia: optimising short- and
long-term treatment using asenapine
L. Cortese (Canada)
| 12.30-13.30 | Workshop WOp/e3 |
UNA EXCURSIÓN POR EL MUNDO CATATÓNICO
A. Monchablon, M. Derito, D. Saferstein (Argentina)
| 12.30-13.30 | Workshop WOp/e4 |
HISTERIA, TRASTORNO LÍMITE Y PSICOSIS: DEBATES ACTUALES SOBRE NOSOGRAFÍA Y DIAGNÓSTICO DIFERENCIAL
G. Belaga, P. Dreschler, M. Spivacoff, J.C. Tenconi (Argentina)
| 13.30-14.30 | Workshop WOp/e5 |
MELANCOLIA Y MUSICA TRADICIONAL
S. Villaseñor-Bayardo, J.E. Dimov, C. Mella (Argentina/República Dominicana)
| 13.30-14.30 | Workshop WOp/e6 |
TRASTORNOS PSICOTICOS DE INICIO EN LA TERCERA EDAD: DESAFIOS DIAGNOSTICOS Y TERAPEUTICOS
J.L. Carrera, F. Lamaison, N. Perotti, J. Rezzonico, V. Gobbi, C. Espinoza Viale (Argentina)
| 14.45-16.15 | KEYNOTE LECTURES |
Chairperson: P. Ruiz (USA)
KL3 Community mental health care: recent developments and new trends
G. Thornicroft (UK)
KL4 Supported employment for people with serious mental illnesses
R.E. Drake (USA)
| 14.45-16.15 | Regular Symposium RS10 |
CROSS-CUTTING DIMENSIONAL MEASURES IN THE DSM-5
Chairperson: D. Kupfer (USA)
RS10.1 The DSM-5 and the use of cross-cutting dimensional measures in adults
D. Regier (USA)
RS10.2 Cross-cutting scales for child psychiatry
D. Shaffer (USA)
RS10.3 Anticipating DSM-5: innovations and field trials for psychotic disorders
W.T. Carpenter (USA)
RS10.4 DSM-5 neurocognitive disorders: revisions in response to public input and field trials
D. Jeste (USA)
RS10.5 Including functioning and disability concepts in the DSM-5
W. Narrow (USA)
Discussant: W. Gaebel (Germany)
| 14.45-16.15 | Regular Symposium RS11 |
ARE THERE BIOMARKERS FOR SCHIZOPHRENIA?
Chairpersons: S. Galderisi (Italy), W. Strik (Switzerland)
RS11.1 Is P300 low amplitude a biomarker for schizophrenia?
S. Galderisi (Italy)
RS11.2 Electrophysiological correlates of negative symptoms/deficit syndrome schizophrenia
N. Boutros (USA)
RS11.3 Resting state networks and the language system in schizophrenia
W. Strik, H. Horn, K. Jann, S. Walther, A. Federspiel, M. Wirth, T. Müller (Switzerland)
| 14.45-16.15 | Regular Symposium RS12 |
NEW RESEARCH ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Chairperson: J. Biederman (USA)
RS12.1 Do stimulants have a protective effect on the development of psychiatric disorders in youth with ADHD? A ten-year follow-up study
J. Biederman (USA)
RS12.2 Genome-wide association scan of attention-deficit/hyperactivity disorder
S. Faraone, for the ADHD GWAS Consortium (USA)
RS12.3 Brain correlates of ADHD behaviors in medication-naive adults with ADHD: a controlled MRI study
N. Makris (USA)
RS12.4 Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS–methylphenidate in adults with ADHD
T. Spencer (USA)
| 14.45-16.15 | Regular Symposium RS13 |
ENDURING MENTAL HEALTH EFFECTS OF COLONIALISM ON POST COLONIAL PEOPLES
Chairperson: F.W. Hickling (Jamaica)
RS13.1 History casts a long shadow: the European scotomata of the mental health effects of colonialism
J. Guzder (Canada)
RS13.2 Naming the pain: concepts of intergenerational trauma
H. Robertson-Hickling, F.W. Hickling (Jamaica)
RS13.3 The call for an international apology from psychiatric services and professions: emancipating indigenous people with mental illnesses from the "double-whammy" colonization by both imperial powers and psychiatry
A. Rosen (Australia)
RS13.4 Cultural oppression, paranoia and competent diagnosis ofschizophrenia in African Americans
A.L. Whaley (USA)
| 14.45-16.15 | Regular Symposium RS14 |
REWARD SYSTEM DYSFUNCTION IN ADDICTION: GENETIC AND NEUROBIOLOGICAL FOUNDATIONS, IMPACT ON LIFE QUALITY AND THERAPEUTIC INTERVENTIONS
Chairpersons: A. Heinz (Germany), M. Musalek (Austria)
RS14.1 The IMAGEN study: gene x neuroimaging analysis of reward and substance use behaviour in 14-year old adolescents
G. Schumann (UK)
RS14.2 Reward learning dysfunction in addiction
A. Heinz, U. Kluge, A. Beck (Germany)
RS14.3 Quality of life as health indicator among individuals with addiction and complex concurrent disorders
M. Krausz, A. Karow (Canada/Germany)
RS14.4 Resource-oriented treatment of addiction: the Orpheus Program
M. Musalek (Austria)
| 14.45-16.15 | Regular Symposium RS15 |
CURRENT RESEARCH IN TRANSCULTURAL PSYCHIATRY IN SCANDINAVIAN COUNTRIES
Chairperson: M. Kastrup (Denmark)
RS15.1 How to increase staff competence in transcultural psychiatry: the Danish experience M. Kastrup (Denmark)
RS15.2 Building bridges for mental health and rehabilitation in an Arctic archipelago
P.R. Jessen, R. Ruud (Norway)
RS15.3 Transcultural telepsychiatry: overcoming barriers in provision ofmental health care
D. Mucic (Denmark)
RS15.4 Telepsychiatry in Greenland
P. Bisgaard (Greenland)
| 14.45-16.15 | Section Symposium SS6 |
THE ROLE OF PSYCHIATRY AND MENTAL HEALTH IN CANCER CARE
(organized by the WPA Section on Psycho-Oncology and Palliative Care, in collaboration with the International Psycho-Oncology Society)
Chairpersons: L. Grassi (Italy), M. Riba (USA)
SS6.1 Online multilingual core curriculum in psycho-oncology an international perspectives
L. Grassi, R. Caruso, C. Da Ronch, M.G. Nanni (Italy)
SS6.2 Psychosocial factors and role of the psychiatrist in patients with neurological cancer
M.F. Mutti, R. Fahrer (Argentina)
SS6.3 Immunomodulator treatment in cancer patients with Hashimoto thyroiditis
F. Matozza, D. Levy (Argentina)
SS6.4 Differential diagnoses in primary care
D. Baron (USA)
SS6.5 Quality of life in palliative care: what do we know about Chilean and Latin-American cancer caregivers?
M.E. Irarrázaval, P. San Martín (Chile)
| 14.45-16.15 | Section Symposium SS7 |
THE ECONOMICS OF MENTAL HEALTH REFORM (organized by the WPA Section on Mental Health Economics)
Chairpersons: T. Ruud (Norway), M. Moscarelli (Italy)
SS7.1 The impacts of Norway's ten year national plan for mental health (1999-2008)
T. Ruud (Norway)
SS7.2 The impact of national health reform on adults with mental disorders
R.L. Garfield, S.H. Zuvekas, J.R. Lave, J.M. Donohue (USA)
SS7.3 Financing the access to patient reported outcomes information in schizophrenia
M. Moscarelli (Italy)
| 14.45-16.15 | Section Symposium SS8 |
IMPULSIVITY IN BIPOLAR AND RELATED DISORDERS: MECHANISMS AND SPECIFICITY (organized by the WPA Section on Impulsivity and Impulse Control Disorders)
Chairperson: A. Swann (USA)
SS8.1 Impulsivity, course of illness, and addictive behavior in bipolar disorder
A. Swann, M. Lijffijt, S. Lane, J. Steinberg, F. Moeller (USA)
SS8.2 A comparison of impulsivity characteristics among subjects with bipolar disorder and pathological gambling
D. Rossini, C. Castanho de Almeida Rocca, B. Lafer, H. Tavares (Brazil)
SS8.3 Impulsivity in bipolar disorder: a sib pair study
K. Almeida, F. Nery, B. Lafer (Brazil)
SS8.4 Bipolar disorder, co-occurring alcoholism and family history: impulsivity as a trait marker and neurobiological underpinnings
J. Soares, E. Henna, F. Nery, G. Zunta-Soares, J. Hatch, A. Swann (USA)
Discussant: J. Soares (USA)
| 14.45-16.15 | Zonal Symposium ZS5 |
MENTAL HEALTH CHALLENGES IN SOUTH ASIA: THE CURRENT SCENARIO (organized by the WPA Southern Asia Zone)
Chairpersons: E. Mohandas (India), P. Deva (Malaysia)
ZS5.1 Mental health challenges in Sri Lanka
J. Mendis (Sri Lanka)
ZS5.2 Mental health challenges in Malaysia
H. Habil (Malaysia)
ZS5.3 Challenges in mental health care in the Philippines
J. Te-Sy (Philippines)
ZS5.4 Mental health challenges in Bangladesh
G. Rabbani (Bangladesh)
ZS5.5 Mental health challenges in Nepal
D. Shakya (Nepal)
| 14.45-16.15 | Zonal Symposium ZS6 |
DEVELOPING PRIMARY CARE MENTAL HEALTH IN EUROPE: FROM RESEARCH TO PRACTICE (organized by the WPA Western Europe and Southern Europe Zones)
Chairpersons: L. Gask (UK), M. Roca (Spain)
ZS6.1 Developing the primary care/specialist interface in Ireland
V. Russell, A. Jeffers (Ireland)
ZS6.2 Effectiveness of collaborative care for depression and anxiety in primary care in The Netherlands: results of multiple randomized controlled trials
C.M. van der Feltz-Cornelis, A.D.T. Munting, K.M.L. Huijbregts, F.J. de Jong, H.W.J. van Marwijk, A.T.F. Beekman, A.J.M.L. van Balkom, H.J. Adèr, P. Spinhoven (The Netherlands)
ZS6.3 Referral criteria from primary care health services to psychiatric settings
M. Roca (Spain)
ZS6.4 Improving access to mental health in primary care: a novel, community based intervention
L. Gask (UK)
Discussant: L. Küey (Turkey)
| 14.45-16.15 | Simposio Regular RSp/e7 |
INVESTIGACIÓN PSIQUIÁTRICA EN AMÉRICA LATINA: SELECCIÓN DE ESTUDIOS RECIENTES Y DIRECCIONES FUTURAS
Presidente: R. Castilla (EE.UU.)
RSp/e7.1 Desafíos en el diagnóstico de depresión en los servicios de urgencia de Latinoamérica
A. Grau Martínez (Chile)
RSp/e7.2 La mujer, la inmigración y salud mental
S. Gaviria (Colombia)
RSp/e7.3 Difusión de la investigación en salud mental en América Latina: problemas actuales y futuras direcciones
E. Velásquez (Colombia)
| 14.45-16.15 | Simposio Regular RSp/e8 |
LA VIOLENCIA: DEL CONOCIMIENTO A LA INTERVENCIÓN
Presidente: A. Smaili Marín (Venezuela)
RSp/e8.1 Neurobiología de la violencia
A. Smaili Marín (Venezuela)
RSp/e8.2 La violencia domestica: definición, ciclo, y mitos
M. Sierra (República Dominicana)
RSp/e8.3 De la violencia a la delincuencia
L. Silveira (Venezuela)
RSp/e8.4 Tratamiento psicoterapéutico en mujeres víctimas de violencia doméstica
V.M.E. Duran Ramirez (Venezuela)
| 14.45-16.15 | Simposio Regular RSp/e9 |
EL DIAGNOSTICO GENETICO EN EL CANCER. ASPECTOS PSICOSOCIALES
Presidente: M. del C. Vidal y Benito (Argentina)
RSp/e9.1 El diagnostico genético en cáncer. Aspectos interdisciplinarios
M. del C. Vidal y Benito (Argentina)
RSp/e9.2 Cáncer hereditario. Aspectos clínicos y asesoramiento genético
L. Nuñez (Argentina)
RSp/e9.3 Aspectos psicosociales en el cáncer hereditario
D. Telias (Argentina)
| 14.45-16.15 | Simposio Regular RSp/e10 |
ESTRES POSTRAUMATICO EN VETERANOS DE LA GUERRA DE MALVINAS (1982)
Presidente: E. Stein (Argentina)
RSp/e10.1 29 años después de la guerra de Malvinas
M.M. Bourdieu (Argentina)
RSp/e10.2 Trastorno de estrés postraumático (TEPT) y patologías relacionadas
A. Lopez Ruiz (Argentina)
RSp/e10.3 Estrés postraumático: ¿mito o realidad? (Los Veteranos de la Guerra
de Malvinas)
E. Stein (Argentina)
RSp/e10.4 Los medios de comunicación y la salud mental de lo Veteranos de
Guerra de Malvinas
G.I. Bellatti (Argentina)
| 16.30-18.00 | KEYNOTE LECTURES |
Chairperson: A. Tasman (USA)
KL5 The evidence base for psychodynamic therapy
P. Fonagy (UK)
KL6 Cognitive-behavioral psychotherapies: their heritage and future
K. Shear (USA)
| 16.30-18.00 | Special Symposium SPS2 |
WPA WORKING TOGETHER WITH SERVICE USERS AND CARERS
Chairperson: H. Herrman (Australia)
SPS2.1 The WPA project on partnerships with service users and carers
H. Herrman (Australia)
SPS2.2 What has been learned from working between mental health professionals, patients and users of psychiatric services, their families and friends?
J. Wallcraft (UK)
SPS2.3 Including family carers, consumers and family and consumer organizations in mental health care worldwide
D. Froggatt (Australia)
SPS2.4 Agreements and balances in working in partnerships in mental health
M. Amering (Austria)
| 16.30-18.00 | Regular Symposium RS16 |
CROSSING THE QUALITY CHASM IN PSYCHIATRY: EXPERIENCES AND LESSONS FROM AROUND THE WORLD
Chairperson: H.A. Pincus (USA)
RS16.1 Overview and findings from the International Initiative for Mental Health Leadership (IIMHL) project
H.A. Pincus (USA)
RS16.2 European guidance on quality of mental health services
W. Gaebel (Germany)
RS16.3 Measuring quality of mental health care in Norway
T. Ruud (Norway)
RS16.4 National strategies for measuring mental health quality in Japan
H. Ito, T. Noda, N. Sugiyama, T. Kuroki, S. Matsushita, T. Hirata (Japan)
RS16.5 Mental health quality and outcome measurement and improvement in Scotland
D. Coia (UK)
| 16.30-18.00 | Regular Symposium RS17 |
NEURAL NETWORKS AND MECHANISMS UNDERLYING ANXIETY: PERSPECTIVES FROM FUNCTIONAL NEUROIMAGING RESEARCH
Chairperson: M. Ernst (USA)
RS17.1 Stress, emotions and cognition: lessons from studying neurocircuitry in post-traumatic stress disorder
I. Liberzon (USA)
RS17.2 Fear, anxiety, and models of anxiety disorders
C. Grillon (USA)
RS17.3 At the interface of belief and feeling: dysfunction of medial prefrontal cortex during self-assessment and of insula during emotion processing in anxiety
M.P. Paulus, M.B. Stein (USA)
RS17.4 Behavioral and functional magnetic resonance imaging studies of cognitive perturbations in anxiety disorders. A developmental perspective
M. Ernst (USA)
| 16.30-18.00 | Regular Symposium RS18 |
COERCION AND PSYCHIATRY: RESULTS FROM THE EUNOMIA COLLABORATIVE STUDY
Chairpersons: T.W. Kallert (Germany), A. Fiorillo (Italy)
RS18.1 Legal and ethical aspects of research on the use of coercion in psychiatry
T.W. Kallert (Germany)
RS18.2 Outcomes of involuntary hospital admissions
S. Priebe (UK)
RS18.3 Use of coercive measures during involuntary hospitalization: findings from ten European countries
J. Raboch (Czech Republic)
RS18.4 Acute psychopathology as a predictor of prospective global functioning in patients suffering from psychosis: a study in 11 European countries
F. Torres-Gonzales (Spain)
RS18.5 How to improve clinical practice on involuntary hospital admissions of psychiatric patients: results from the EUNOMIA study
A. Fiorillo (Italy)
| 16.30-18.00 | Regular Symposium RS19 |
ADVANCES IN HIV MENTAL HEALTH AND PREVENTION INTERVENTIONS
Chairperson: T. Hall (USA)
RS19.1 Recognizing variety among male homosexual identities: challenges for behavioral medicine
T. Hall (USA)
RS19.2 A pilot study of a trauma-based HIV risk reduction intervention for Mexican American men with histories of childhood sexual abuse
A. Sciolla (USA)
RS19.3 Should HIV testing be routine for psychiatric patients in inpatient and outpatient settings?
R. Daroff (USA)
RS19.4 A therapeutic writing group for men and women living with HIV/AIDS
A. Peterkin (Canada)
| 16.30-18.00 | Regular Symposium RS20 |
CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN CANADA
Chairpersons: L.J. Kirmayer (Canada), J. Guzder (Canada)
RS20.1 The mental health of indigenous peoples in Canada
L.J. Kirmayer (Canada)
RS20.2 Cultural psychiatry in the Canadian context: a view from child psychiatry
J. Guzder (Canada)
RS20.3 Social factors and the mental health of diverse populations in Canada: a literature review and synthesis
K. McKenzie (Canada)
RS20.4 Cultural psychiatry training in Canada
L. Dabby (Canada)
RS20.5 The social origins of stigma related to mental illness: preliminary results of an epidemiologic catchment area study in Montreal
D. Pedersen (Canada)
| 16.30-18.00 | Workshop WO2 |
FAMILY-BASED TREATMENT OF FIRST EPISODE AND PRODROMAL PSYCHOSIS: A TREATMENT UPDATE
W.R. McFarlane (USA)
| 16.30-18.00 | Workshop WO3 |
PSYCHIATRIC BRAIN DRAIN AND ITS POSSIBLE SOLUTIONS
M.P. Deva, A. Javed, R. D’Souza, P. Ruiz, E. Mohandas (Malaysia/UK/Australia/USA/India)
| 16.30-18.00 | Section Symposium SS9 |
21st CENTURY APPROACHES TO PSYCHIATRIC GENETIC RESEARCH
(organized by the WPA Section on Genetics in Psychiatry)
Chairpersons: W. Maier (Germany), T.G. Schulze (Germany/USA)
SS9.1 From GWAS to sequencing to functional studies: experiences from schizophrenia genetics
P.V. Gejman (USA)
SS9.2 Pharmacogenetics and neuroimaging: understanding potential mechanisms for antidepressant treatment response
G. Laje (USA)
SS9.3 Epigenetics: the epitome of missing heritability?
J.B. Potash (USA)
SS9.4 The phenotype: the still unknown quantity in psychiatric genetics?
T.G. Schulze (Germany/USA)
| 16.30-18.00 | Section Symposium SS10 |
PSYCHIATRY OF INTELLECTUAL DISABILITY: CONTRIBUTION TO THE ICD-11 (organized by the WPA Section on Psychiatry of Intellectual Disability)
Chairperson: N. Bouras (UK)
SS10.1 “Intellectual developmental disorders” and the international classification of diseases
L. Salvador-Carulla (Spain)
SS10.2 Mental retardation: intellectual or cognitive disorder?
M.O. Bertelli (Italy)
SS10.3 Behavioural features in the new classification system for intellectual disabilities
S.-A. Cooper (UK)
SS10.4 Implications for low- and middle-income countries
G. Katz (Mexico)
SS10.5 Clinical outcomes of a specialist inpatient unit for adults with intellectual disabilities and mental health problems
H. Kwok, K.K. Chun, W. Wong, M. To (China)
| 16.30-18.00 | Section Symposium SS11 |
DEPRESSION AS AN INFLAMMATORY DISEASE (organized by the WPA Section on Biological Psychiatry)
Chairpersons: M. Maes (Thailand), M. Abou-Saleh (UK)
SS11.1 The role of inflammatory, oxidative and nitrosative stress pathways in depression
M. Maes (Thailand)
SS11.2 Inflammation and major depression: the role of TH1/TH2 shift in neuroimmune interactions and its relevance in cancer prognosis
L.R. Frick (Argentina)
SS11.3 Genetic variants of major inflammatory enzymes in patients with depression
P. Galecki (Poland)
SS11.4 Evidence of mitochondrial dysfunction in bipolar disorder: findings from postmortem brain and peripheral cells
A. Andreazza (Canada)
| 16.30-18.00 | Simposio Regular RSp/e11 |
NUEVAS PERSPECTIVAS EN TRASTORNO BIPOLAR
Presidente: G.H. Vázquez (Argentina)
RSp/e11.1 Pros y contras de la terapia combinada versus monoterapia en el
trastorno bipolar
E. Vieta (España)
RSp/e11.2 Estatificación y guías de tratamiento para los trastornos bipolares
F. Kapczinski (Brasil)
RSp/e11.3 Balance beneficio/riesgo en el tratamiento a largo plazo de los
trastornos bipolares
J.M. Tamayo (Colombia)
RSp/e11.4 Investigación en Latinoamérica sobre el trastorno bipolar
M. Tohen (USA)
| 16.30-18.00 | Simposio Regular RSp/e12 |
DEPRESIONES "NO TIPICAS"
Presidente: J.Á. Saviñon (República Dominicana)
RSp/e12.1 Investigación educativa: aspectos teórico-clínicos de la depresión
enmascarada y antecedentes de la investigación
E.O. Allegue (Argentina)
RSp/e12.2 Investigación educativa: desarrollo, análisis de datos y resultados
R.H. Carroll (Argentina)
RSp/e12.3 ¿La depresión en los ancianos es un trastorno atípico?
E. Klubok (Argentina)
RSp/e12.4 Nosografía de depresiones no típicas para la ICD-10 y DSM-IV -
nosografía y actualización en depresión posparto
M.A. Zukierman (Argentina)
| 16.30-18.00 | Simposio Regular RSp/e13 |
EPIGENÉTICA: FUNDAMENTOS Y POTENCIAL MODULACIÓN
Presidente: C. Soria (Argentina)
RSp/e13.1 Epigenética: factores postnatales
C. Soria (Argentina)
RSp/e13.2 Epigenética: factores prenatales
C. Remedi (Argentina)
RSp/e13.3 Las influencias del estilo de vida sobre los genes
F. Celnikier (Argentina)
| 16.30-18.00 | Simposio Regular RSp/e14 |
AVANCES EN PSIQUIATRÍA TRANSCULTURAL EN LOS PAÍSES DE HABLA HISPANA
Presidente: J. Achotegui (España)
RSp/e14.1 Nuevos datos sobre el Síndrome de Ulises en inmigrantes en España
J. Achotegui (España)
RSp/e14.2 El Síndrome de Ulises en población infantojuvenil
D. Espeso (España)
RSp/e14.3 Validación de la escala de Ulises en inmigrantes peruanos
J. López Rodas (Perú)
RSp/e14.4 Psiquiatría cultural en América Latina
S. Vilaseñor-Bayardo (Méjico)
| 18.15-19.45 | Core Symposium CS4 |
GENE-ENVIRONMENT INTERACTIONS IN MENTAL DISORDERS
Chairperson: N. Craddock (UK)
CS4.1 Genetic and phenotypic complexity in psychiatric disorders
N. Craddock (UK)
CS4.2 Genetic sensitivity to the environment underlying psychosis and depression: clinical relevance
J. van Os (The Netherlands)
CS4.3 The complex interplay between genetic and environmental factors in the development of alcohol addiction
M. Rietschel (Germany)
| 18.15-19.45 | Core Symposium CS5 |
THE FAMILY OF PERSONS WITH SEVERE MENTAL ILLNESS
Chairperson: K.T. Mueser (USA)
CS5.1 Impact of care and coping in families of people with psychosis
E. Kuipers (UK)
CS5.2 The changing face of family psychoeducation over time and culture
K.T. Mueser (USA)
CS5.3 Models of family interventions: views of family caregivers
R. Shankar (India)
| 18.15-19.45 | Regular Symposium RS21 |
HOMELESSNESS AND MENTAL ILLNESS
Chairperson: C. Caton (USA)
RS21.1 Homelessness and mental illness in the world’s developed countries
C. Caton (USA)
RS21.2 Does active substance use at housing entry impair outcomes in supported housing for chronically homeless persons?
R. Rosenheck, E. Edens, J. Tsai, A. Mares (USA)
RS21.3 Pathways’ housing first: international perspectives on ending homelessness and promoting recovery for people with dual diagnoses
S. Tsemberis (USA)
RS21.4 Promoting social inclusion using implementation science
G. Thornicroft (UK)
| 18.15-19.45 | Regular Symposium RS22 |
ADVANCES IN NEUROSTIMULATION THERAPIES FOR TREATMENT RESISTANT DEPRESSION
Chairperson: M.M. Husain (USA)
RS22.1 Electroconvulsive therapy in the management of depression: report from the CORE trial
G. Petrides (USA)
RS22.2 Magnetic stimulation therapy for the treatment of depression
M.M. Husain (USA)
RS22.3 Development of deep brain stimulation in the treatment of depression
D. Malone (USA)
| 18.15-19.45 | Regular Symposium RS23 |
ADVANCES IN PEDIATRIC OBSESSIVE-COMPULSIVE DISORDER
Chairperson: E.A. Storch (USA)
RS23.1 D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder
E.A. Storch, T.K. Murphy, W.K. Goodman, G. Geffken, A. Lewin, A. Henin, J. Micco, S. Sprich, S. Wilhelm, M. Bengston, D. Geller (USA)
RS23.2 Quality of life in youth with obsessive-compulsive disorder
C.W. Lack, E.A. Storch, G.R. Geffken, E.D. Ricketts, T.K. Murphy (USA)
RS23.3 Neuro-executive predictors of cognitive-behavioral treatment response in youth with obsessive-compulsive disorder
A.B. Lewin, J.R. Morgan, M.J. Larson, J. Park, D. Venosa, T.K. Murphy, E.A. Storch (USA)
RS23.4 Impact of disruptive behavior disorders on cognitive-behavioral treatment response in pediatric obsessive-compulsive disorder
G. Geffken, E.A. Storch, M. Larson, T.K. Murphy (USA)
Discussant: D. Stein (USA)
| 18.15-19.45 | Regular Symposium RS24 |
CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN FRANCE
Chairperson: R. Bennegadi (France)
RS24.1 Providing mental health care to migrants: the clinical medical anthropology approach adapted to the French mental health system
S. Consoli (France)
RS24.2 Specialized mental health care in France: a genealogy
S. Larchanché (France)
RS24.3 Psychoanalytic perspective and migration
V. Sommer (France)
RS24.4 Psychotherapy and migration: cultural competence as the newparadigm in mental health care in France
R. Bennegadi (France)
| 18.15-19.45 | Workshop WO4 |
LOVE AND JEALOUSY: FROM NEUROBIOLOGY TO HUMANITIES
D. Marazziti, B. Cardoso (Italy/Brazil)
| 18.15-19.45 | Section Symposium SS12 |
RETHINKING PSYCHOSIS: CONCEPTS AND CORE PSYCHOPATHOLOGICAL FEATURES (organized by the WPA Section on Clinical Psychopathology)
Chairpersons: S. Opjordsmoen (Norway), A. Raballo (Denmark/Italy)
SS12.1 Diagnostic symptoms versus core psychopathology
W.T. Carpenter (USA)
SS12.2 The self in psychosis: striving for psychopathological coherence beyond the crust of diagnostic symptoms
A. Raballo (Denmark/Italy)
SS12.3 Insight in psychosis? Past and new directions
J.A. Engh (Norway)
SS12.4 Incomprehensibility and psychosis
M. Heinimaa (Finland)
| 18.15-19.45 | Section Symposium SS13 |
INSOMNIA: THE EXTENT OF THE PROBLEM AND ITS CONSEQUENCES (organized by the WPA Section on Psychiatry and Sleep Wakefulness Disorders)
Chairpersons: M. Berger (Germany), C. Soldatos (Greece)
SS13.1 Epidemiological considerations regarding insomnia
T. Paparrigopoulos (Greece)
SS13.2 The hyperarousal hypothesis of primary insomnia
M. Berger, D. Riemann, C. Nissen (Germany)
SS13.3 Cognitive and emotional consequences of insomnia
C. Nissen, D. Riemann, C. Baglioni, M. Berger (Germany)
| 18.15-19.45 | Section Symposium SS14 |
BODY-MIND CONNECTION THROUGH THE IMMUNE SYSTEM: CLINICAL AND BIOCHEMICAL ASPECTS IN SCHIZOPHRENIA (organized by the WPA Section on Immunology and Psychiatry)
Chairpersons: N. Müller (Germany), M.H. Rapaport (USA)
SS14.1 Controversies on cytokine changes and effects of antipsychotics in schizophrenia
M.H. Rapaport (USA)
SS14.2 Controversies on kynurenine changes in schizophrenia: the pathophysiological aspect
A.M. Myint, M.J. Schwarz, R. Verkerk, M. Riedel, Y.K. Kim (Germany/Belgium/Korea)
SS14.3 Immune alterations and the kynurenine pathway in schizophrenia: pharmacological effects on immune neurochemical systems interaction
M.J. Schwarz, A.M. Myint, M. Riedel, N. Müller (Germany/Belgium)
SS14.4 Role of neuroimmunomodulation as a new therapeutic strategy in schizophrenia
N. Müller (Germany)
| 18.15-19.45 | Zonal Symposium ZS7 |
FROM THE NORTH TO THE SOUTH: PSYCHIATRIC EDUCATION IN THE AMERICAS (organized by the WPA Canada and United States of America Zones)
Chairpersons: R. Tempier (Canada), M. Riba (USA)
ZS7.1 Psychiatric education in Canada: past, present and future
R. Tempier (Canada)
ZS7.2 Choosing psychiatry as a career: current issues in the USA
M. Riba (USA)
ZS7.3 Becoming a psychiatrist in Chile: opportunities and challenges
S. Barroilhet (Chile)
ZS7.4 Psychiatry in Guatemala: highlights on education
S.-K. Quinto (Guatemala)
| 18.15-19.45 | Zonal Workshop ZW1 |
NATIONAL MANIFESTOS FOR PSYCHIATRY IN NORTHERN EUROPE
(organized by the WPA Northern Europe Zone)
H. Wahlberg, J. Korkeila (Sweden/Finland)
| 16.30-18.00 | Simposio Regular RSp/e15 |
CLOZAPINA EN ESQUIZOFRENIA RESISTENTE
Presidente: G.S. Jufe (Argentina)
RSp/e15.1 Mecanismo de acción de la clozapina. Correlación con sus efectos
terapéuticos y adversos
G.S. Jufe (Argentina)
RSp/e15.2 Esquizofrenia resistente: terreno de múltiples desafíos
I.M. Elenitza (Argentina)
RSp/e15.3 Neurobiología de la esquizofrenia resistente
F. Garitano-Zavala (Bolivia)
RSp/e15.4 Uso de clozapina en un hospital de emergencias psiquiátricas. Un
estudio transversal
B.G. Lopez (Argentina)
| 16.30-18.00 | Simposio Regular RSp/e16 |
DELIRIOS CRONICOS: ¿UNA ESPECIFICIDAD FRANCESA?
Presidente: J.C. Stagnaro (Argentina)
RSp/e16.1 Los delirios: clasificación, historia y actualidad
J. Garrabé (Francia)
RSp/e16.2 ¿Qué estatuto para los temas delirantes?
M. Reca (Francia)
RSp/e16.3 El diagnóstico de parafrenia: ¿una excepción francesa?
D. Wintrebert (Francia)
| 18.15-19.45 | Workshop WOp/e7 |
FRACASO Y DESERCIÓN EN EL SISTEMA EDUCATIVO. ESPECIFICIDADES PSICO-AFECTIVAS, COGNITIVAS Y DE ADAPTABILIDAD GRUPAL
P. Alterwain, E. Romano (Argentina)
| 18.15-19.45 | Workshop WOp/e8 |
EL ROL DEL PSIQUIATRA INFANTO JUVENIL EN LA ARGENTINA DE HOY
L. Moneta, A. Meléndez, M. Moreno, M. Turtela (Argentina)